Don’t forget to submit your Analytical Division abstract for the fall ACS meeting in Boston (April 8) before heading off to the spring ACS meeting in Orlando (April 7). Yes, it is on-line abstract submission, but the long lead-time from paper abstract days is still in place.
GenomeWeb is reporting that Applied Biosystems and MDS won their patent suit against Micromass to the tune of $47.5M. The patent in question is US4963736: Mass spectrometer and method and improved ion transmission, which ABI and MDS call technology for “triple quadrupole mass spectrometers.” Also see CNNMoney and Reuters financial news stories.
MS among other techniques for biological weapons detection: The Science of Detecting Terror in the March 1 Analytical Chemistry A-pages.
I added proteomics and genomics stories to the newsfeed. This picks up MS stories that don’t explicitly mention MS, for example this recent article about SEQUENOM and SNP assays.
The 16th International Mass Spectrometry Conference will be held in Edinburgh, Scotland, between August 31st and September 5th 2003. That’s still a long way off, but it’s worth bookmarking the 16th IMSC Web page at http://www.imsc-edinburgh2003.com/. There’s no link back to the International Mass Spectrometry Society on the page, so here it is: http://www.imss.nl/. Note that the IMSS site is on a Netherlands server and has a “.nl” rather than a “.com” or “.org” Web address.
Welcome to my mass spectromery Web log or “blog” as they are called. Blogs are Web pages that consist of chronologically arranged lists similar to journal entries or news reports. The purpose of this blog is to record items of interest that I find on the Internet that I think will be of interest to the mass spectrometry community. I do this anyway as editor of Basepeak and the Mass Spectrometry Internet Resources FAQ; I’m hoping that blogging will make this easier. My philosophy from the early days of “Mass Spectrometry on the Internet” has been to try any Internet format and see how it plays with the MS crowd. Some things have worked and some haven’t. We’ll give this a go.